Imagen Therapeutics

To improve the outcomes of cancer patients by accelerating drug discovery and the development of new cancer therapies.

[The ICR @ICR_London]

🌍 Today on World #LungCancerDay, check out our blog post with Dr Paul Huang (@HuangLabICR) about how targeted drugs, like EGFR inhibitors, are changing the landscape of #LungCancer treatment.

Read more 👇
https://t.co/5YJxn2a8DO

#WorldLungCancerDay #WLCD2021

[Imagen Therapeutics @ImagenTx]

August 1st marks #WorldLungCancerDay, the 2nd most diagnosed cancer in the world and leading cause of cancer death, last year totaling 1.8 million in deaths. Reach out to find out how we support patients with these types of cancers through our patient-centric predictRx service.

[Imagen Therapeutics @ImagenTx]

“Low-passage, serum-free cell lines cultured from patient tumour tissue are the gold-standard for preclinical studies and cellular investigations of glioblastoma (GBM) biology.” – Stringer et al. 2019 https://t.co/EBhm9UVLIt

Read about the high phenotypic conservation below.

[Imagen Therapeutics @ImagenTx]

A unique mode of action requires a unique biomarker assay. Reach out to discuss our custom assay development capabilities -> https://t.co/ArcQ8Ke5Qq

Image: assessment of aurora inhibitor effects in MCF7 cells. Green = Tubulin, Blue = Hoechst

[Imagen Therapeutics @ImagenTx]

#ThrowbackThursday to this beauty – using paclitaxel on MCF7 cells to develop our machine learning algorithm for cell analysis. Green = Tubulin, Red = Draq7, Blue = Hoechst.

[Imagen Therapeutics @ImagenTx]

Our CSO and founder Gareth Griffiths is a true HCS expert, developing and validating over 100 phenotypic assays, in both 2D and 3D patient-derived cell (PDC) models for drug development.

Contact us to learn how our HCS expertise and models can benefit your drug development.

[Imagen Therapeutics @ImagenTx]

This month is skin, brain and bladder cancer awareness month, all vastly different but our awareness and support is agnostic. Whether you’re a patient or an oncologist tackling these cancers, reach out to us and see how we can help -> https://t.co/ArcQ8Ke5Qq

[The ICR @ICR_London]

"Covid is important but cancer is a significant health problem... people with possible signs of cancer should contact their GP" - @clare__turnbull, Professor in Cancer Genomics at the ICR.

Read more in the @guardian 👇
https://t.co/Z8p456A8jL

#Cancer #Covid_19 #CancerAwareness

[Imagen Therapeutics @ImagenTx]

May marks the start of #NationalCancerResearchMonth for our friends over in the States. We appreciate all the work going on to tackle cancer.

Reach out to us to find out how we can aid in your cancer research -> https://t.co/ArcQ8Ke5Qq

[Imagen Therapeutics @ImagenTx]

April marks #HeadandNeckCancerAwarenessMonth, H&N cancer accounts for 3-4% of cancer cases globally but remains at around a 50% mortality rate. Persistent cough? Got a lump that isn’t going away? Please get checked and please be safe.

[Imagen Therapeutics @ImagenTx]

From patient to plate, our models don’t get more clinically relevant than this! Reach out to us for more information on our models -> https://t.co/ArcQ8Ke5Qq

[Imagen Therapeutics @ImagenTx]

Don’t let the word ‘routine’ fool you, this isn’t like any other service you’ll find! Contact us to find out more about our patient-derived models and services -> https://t.co/ArcQ8Ke5Qq

#RareTumours #DrugDiscovery #DrugDevelopment

[The ICR @ICR_London]

Good news! A #CancerDrug discovered here at the ICR has entered a phase I #ClinicalTrial at the @royalmarsdenNHS – and could counteract drug resistance in patients with cancers including acute myeloid #leukaemia.

➡️ https://t.co/8RZVaptv87

[Bayer U.S. 🇺🇸 @BayerUS]

March is #ColorectalCancerAwarenessMonth, a time when we come together to spotlight those living with #colorectalcancer. Join us in showing support and raising awareness. Together we are #OncologyInspired.

[Imagen Therapeutics @ImagenTx]

Now offering our services using our patient-derived cell (PDC) models through https://t.co/xjILmkWzq7. Head over to our website and check out the services we offer.

Follow the link to our website -> https://t.co/2l3aiP7uRs

[Imagen Therapeutics @ImagenTx]

This week marks the start of #ColorectalCancerAwarenessMonth, Colorectal cancer was the 3rd most diagnosed cancer of 2020. While Imagen helps in new cancer therapeutics development, another goal of ours is to help raise awareness of cancer in the support of the cancer community.

[Imagen Therapeutics @ImagenTx]

Direct from patient to plate! Low passage, clinically relevant, in vitro patient-derived cell (PDC) models, check out our process.

Contact us for more information -> https://t.co/ArcQ8Ke5Qq

[Imagen Therapeutics @ImagenTx]

It all started with predictRx at Imagen and remains an instrumental service in our goal to improve a patient’s chance of receiving the optimal treatment. PredictRx also allows us to maintain an unparalleled flow of new patient-derived cell models to support pharma.

[Imagen Therapeutics @ImagenTx]

Roses are red,
Violets are blue,
Imagen’s patient-derived models,
Are waiting for you!

Contact us to learn more -> https://t.co/ArcQ8Ke5Qq

[Imagen Therapeutics @ImagenTx]

#WorldCancerDay – a day to reflect and raise awareness. We hope that the pandemic will end soon so every cancer patient can get the diagnosis and treatment they need. Imagen continues to work hard to support cancer patients & drug development.